Journal
EUROPEAN RADIOLOGY
Volume 31, Issue 10, Pages 7901-7912Publisher
SPRINGER
DOI: 10.1007/s00330-021-07727-x
Keywords
COVID-19; Nomograms; Pneumonia; Tomography; X-ray computed
Funding
- National Natural Science Foundation of China [81871332, 81601461]
- Novel Coronavirus Pneumonia Emergency Key Project of Science and Technology of Hubei Province [2020FCA015]
- Fundamental Research Funds for the Central Universities [2042020kfxg10]
Ask authors/readers for more resources
A radiomics nomogram was developed and validated for timely prediction of severe COVID-19 pneumonia, showing good calibration and discrimination in training, validation, and testing cohorts. The CT-based radiomics model outperformed clinical factors and quantitative CT model alone in terms of discrimination capability and clinical usefulness, providing favorable predictive efficacy for severe COVID-19.
Objectives To develop and validate a radiomics nomogram for timely predicting severe COVID-19 pneumonia. Materials and methods Three hundred and sixteen COVID-19 patients (246 non-severe and 70 severe) were retrospectively collected from two institutions and allocated to training, validation, and testing cohorts. Radiomics features were extracted from chest CT images. Radiomics signature was constructed based on reproducible features using the least absolute shrinkage and selection operator (LASSO) logistic regression algorithm with 5-fold cross-validation. Logistic regression modeling was employed to build different models based on quantitative CT features, radiomics signature, clinical factors, and/or the former combined features. Nomogram performance for severe COVID-19 prediction was assessed with respect to calibration, discrimination, and clinical usefulness. Results Sixteen selected features were used to build the radiomics signature. The CT-based radiomics model showed good calibration and discrimination in the training cohort (AUC, 0.9; 95% CI, 0.843-0.942), the validation cohort (AUC, 0.878; 95% CI, 0.796-0.958), and the testing cohort (AUC, 0.842; 95% CI, 0.761-0.922). The CT-based radiomics model showed better discrimination capability (all p < 0.05) compared with the clinical factors joint quantitative CT model (AUC, 0.781; 95% CI, 0.708-0.843) in the training cohort, the validation cohort (AUC, 0.814; 95% CI, 0.703-0.897), and the testing cohort (AUC, 0.696; 95% CI, 0.581-0.796). Decision curve analysis demonstrated that in terms of clinical usefulness, the radiomics model outperformed the clinical factors model and quantitative CT model alone. Conclusions The CT-based radiomics signature shows favorable predictive efficacy for severe COVID-19, which might assist clinicians in tailoring precise therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available